WHO ICTRP trial
Randomized Phase 2 study testing two conditioning regimen with a single…
CTIS2023-509042-35-01 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-509042-35-01 |
|---|---|
| Public title | Randomized Phase 2 study testing two conditioning regimen with a single prophylaxis of graft-versus-host disease by cyclophosphamide and methotrexate post-transplant in patients eligible for matched-donor allograft transplantation _ CY-MET-RIC |
| Scientific title | Randomized Phase 2 study testing two conditioning regimen with a single prophylaxis of graft-versus-host disease by cyclophosphamide and methotrexate post-transplant in patients eligible for matched-donor allograft transplantation _ CY-MET-RIC - RC23_0286 |
| Primary sponsor | Centre Hospitalier Universitaire De Nantes |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | France |
| Conditions | Adults patients will be included in the hematology departments. Eligible patients will be those scheduled to receive an allo-HSC after a RIC conditioning regimen for a myeloid or lymphoid hematological malignancy with a family or non-family… |
| Interventions | Product Name: BUSULFAN, Product Code:SUB05993MIG, Pharmaceutical Form: CONCENTRATE FOR SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: CYCLOPHOSPHAMIDE, Product Code:SUB06859MIG, Pharmaceutical Form… |
| Registration date | Jan 15, 2024 |
| Target size | 60 |
| Secondary IDs | NCT06252870 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: